Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
Takeda Pharmaceuticals: Global Homepage FY2024 Q4 Financial ResultsLearn More Recent News Continuation of the Stock Compensation Plan for Directors and the Stock Grant System for Company Management in Japan in 2025 May 8, 2025 Takeda Announces FY2024 Full Year Results and FY2025 Outlook Reflecting ...
品牌:TAKEDA PHARMACEUTICALS USA INC 包装规格:每片含盐酸吡格列酮(以吡格列酮计)15mg,盐酸二甲双胍0.5g 货号:询 通用名称吡格列酮二甲双胍参比制剂 英文名称/商品名Pioglitazone Hydrochloride and Metformin Hydrochloride 规格每片含盐酸吡格列酮(以吡格列酮计)15mg,盐酸二甲双胍0.5g ...
Takeda Pharmaceuticals U.S.A., Inc. v. Hetero Labs Limited et al (1:17-cv-01020), Delaware District Court, Filed: 07/25/2017 - PacerMonitor Mobile Federal and Bankruptcy Court PACER Dockets
Takeda Pharmaceuticals USA Inc. is taking to the courts once again to try to protect its lucrative gout drug Gol-crys from further generic competition. Takeda sued Zydus Pharmaceuticals USA Inc. in Delaware March 27, alleging its generic version of Colcrys (colchicine) would infringe 17 patents....
The Pharmaceutical Research and Manufacturers of America (PhRMA) elected two new officers to its board of directors. Ramona Sequeira, president of Takeda Pharmaceuticals USA, Inc. was named chair-elect. Sequeira formerly held the position of board treasurer, and when she assumes the role of...
OriginatorMillennium Pharmaceuticals DeveloperCase Western Reserve University; Children's Oncology Group; Eli Lilly and Company; Greehey Childrens Cancer Research Institute; Louisiana State University; Memorial Sloan-Kettering Cancer Center; National Cancer Institute (USA); Nationwide Children's Hospital; PETHE...
Millennium Pharmaceuticals, Inc. INNOVATOR Roushan AFROZE, Indu T. Bharathan,Jeffrey P. CIAVARRI, Paul E. Fleming,Jeffrey L. Gaulin, Mario Girard, Steven P. Langston, Francois R. SOUCY, Tzu-Tshin WONG, Yingchun Ye, A UAE inhibitor potentially for the treatment of solid tumors. TAK-243, ...
Assignee: Takeda Pharmaceutical Company Limited Primary Class: 514/20.3 International Classes: C07K14/81 View Patent Images: Download PDF 20160362475 Related US Applications: Attorney, Agent or Firm: TAKEDA PHARMACEUTICALS USA INC. Claims: 1.A UTI fusion protein, comprising SEQ ID NO:1. ...
Attorney, Agent or Firm: TAKEDA PHARMACEUTICALS USA INC. Parent Case Data: CROSS-REFERENCE TO RELATED APPLICATIONS This application is the U.S. National Stage entry under 35 U.S.C. §371(c) of International Application PCT/US2013/033757, filed Mar. 25, 2013, which claims the benefit of ...